Response to oral β‐carotene supplementation in patients with cystic fibrosis: a 16‐month follow‐up study

Acta Pædiatrica

Volumn 84, Issue 10, 1995, Pages 1132-1136

  Winklhofer‐Roob, BM ^a,b   Van't Hof, MA ^a,b   Shmerling, DH ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFICACY; FOLLOW UP; HUMAN; LIPID ABSORPTION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ANTIOXIDANTS; BETA CAROTENE; CAROTENOIDS; CHILD; CHOLESTEROL; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; FOOD, FORTIFIED; HUMANS; MALE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; VITAMIN A; VITAMIN E;

EID: 0028808364     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1995.tb13512.x     Document Type: Article

References (39)

1. Carotene absorption. A screening test for steatorrhea
2. Improved respiratory prognosis in cystic fibrosis patients with normal fat absorption
3. The roles of bile salts in the uptake of β‐carotene and retinol by rat everted gut sacs
4. Vitamin A, Carotin, retinolbindendes Protein und Präalbumin im Serum von Patienten mit cystischer Fibrose
5. High prevalence of very low beta‐carotene in patients with cystic fibrosis [abstract]
6. Carotenoid levels in normal children and in children with cystic fibrosis
7. Provitamin A function of carotenoids: the conversion of β‐carotene into vitamin A
8. Antioxidant micronutrients and immune responses
9. Actions of carotenoids in biological systems
10. Low beta‐carotene may contribute to the accumulation of free radicals in cystic fibrosis [abstract]
11. Beta‐carotene inhibits lipid peroxidation and improves peroxisomal function in cystic fibrosis [abstract]
12. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during β‐carotene supplementation in cystic fibrosis patients
13. Oxygen free radicals and antioxidants in cystic fibrosis. The concept of an oxidant‐antioxidant imbalance
14. Plasma concentrations of carotenoids after large doses of β‐carotene
15. Beta‐carotene's effect on serum lipoproteins and immunologic indices in humans
16. Rapid serum carotene loading with high‐dose /3‐car‐otene: clinical implications
17. Serum level changes after administration of a pharmacologic dose of β‐carotene
18. Bioavailability of β‐carotene in humans
19. For the Physicians' Health Study Research Group. A randomized trial of aspirin and β‐carotene among U.S.physicians
20. Plasma response of children to short‐term chronic β‐carotene supplementation
21. Pilocarpine iontophoresis sweat testing. Results of seven years' experience
22. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion
23. Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I. The fat‐soluble vitamins A and E, and β‐carotene
24. Long‐term study of one hundred five patients with cystic fibrosis
25. Physical growth of Swiss children from birth to 20 years of age
26. Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high‐performance liquid chromatography on reversed phase
27. Determination of retinyl palmitate in plasma with HPLC. Laboratory procedure
28. Beta‐carotene accumulation in serum and skin
29. The toxicity of beta‐carotene
30. Beta‐carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases
31. The safety of β‐carotene
32. Effects of nutritional status on carotene uptake and bioconversion
33. 13C‐β‐carotene and high precision isotope ratio mass spectrometry
34. Lack of effect of chronic administration of oral β‐carotene on serum cholesterol and triglyceride concentrations
35. Reduction in plasma or skin alpha‐tocopherol concentration with long‐term oral administration of beta‐carotene in humans and mice
36. Carotenodermia in men with elevated carotenoid intake from foods and β‐carotene supplements
37. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol‐binding protein, retinyl esters, carotene, α‐tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A‐supplement users
38. Serum beta‐carotene before and after beta‐carotene supplementation
39. Steady‐state serum concentration of alpha tocopherol not altered by supplementation with oral beta carotene